Intrinsiqs

Is MiMedx Group, Inc. overvalued?

MiMedx Group, Inc. (MDXG) looks undervalued — trading about 125% below its fair value.

Undervalued
Current price $3.21 Fair value $7.23
Price
$3.21
Fair value
$7.23
Current P/E
9.4
Normal P/E
21.3
Market cap
$468.4M
Dividend yield
0.0%
Return on equity
-8.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MDXG's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.